Filing Details

Accession Number:
0001209191-19-028281
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 17:15:57
Reporting Period:
2019-05-07
Accepted Time:
2019-05-08 17:15:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465278 P Joseph Hagan C/o Regulus Therapeutics Inc.
10628 Science Center Dr., #100
San Diego CA 92121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-07 33,194 $1.08 64,542 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant (Right to Buy) Acquisiton 2019-05-07 33,194 $0.13 33,194 $1.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,194 2019-05-07 2024-05-07 No 4 P Direct